Skip to main content

Advertisement

Table 2 Summary of Safety Recommendations for Therapeutic Allergy Procedures (for details, see the text)

From: Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement

Section subtitle Recommended site Emergency equipment availability Emergency Staff (ICU) Availability Duration of supervised follow-up in the office after procedure Comments
Subcutaneous immunotherapy with inhalant allergens Both O and H (a) mandatory (a) available on site (in less than 5 min), or (b) available within 30 min, depending on risk assessment and the immunotherapy protocol used 30 min  
Venom immunotherapy Both O and H (a) mandatory (b) should be available on site, (in less than 5 min) or within 30 min, depending on the risk assessment and the immunotherapy protocol used 30 min  
Drug desensitization procedures O or H depending on risk assessment (a) mandatory (a) available on site (in less than 5 min) 30 min after acute reactions Waiting time can be extended to 24-98 h for delayed reactions
Oral immunotherapy for food allergy Both O and H (a) mandatory available within 5 minutess (a) or available within 30 min (b) depending on risk assessment 2 h Currently not recommended for routine clinical use
Treatment with Anti-IgE and other biologicals   (a) mandatory (b) available within 30 min 2 h for the first administration;30 min for succesive administration  
Treatment with products from human plasma   (a) mandatory (b) available within 30 min 30 min  
  1. O: Outpatient clinic
  2. (a) mandatory
  3. (b) recommended
  4. (c) suggested
  5. (d) not required
  6. H: Hospital setting
  7. (a) available on site (in less than 5 min)
  8. (b) available within 30 min
  9. (c) not required